Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Neal J. Weinreb, Özlem Göker-Alpan, Priya S. Kishnani, et al.
Molecular Genetics and Metabolism (2022) Vol. 136, Iss. 1, pp. 4-21
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Challenges in Gaucher disease: Perspectives from an expert panel
Gregory A. Grabowski, Priya S. Kishnani, Roy N. Alcalay, et al.
Molecular Genetics and Metabolism (2025), pp. 109074-109074
Closed Access | Times Cited: 1
Neurological symptoms in adults with Gaucher disease: a systematic review
Gabriele Imbalzano, Claudia Ledda, Alberto Romagnolo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3897-3907
Open Access | Times Cited: 5
Emerging biomarkers in Gaucher disease
Danielle M Luettel, Márcia R. Terluk, Jaehyeok Roh, et al.
Advances in clinical chemistry (2025), pp. 1-56
Closed Access
Modern Clinical Guidelines for the Management of Patients with Gaucher Disease
И. В. Анисимова, Galina Baydakova, Baranov Aa, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 551-568
Open Access
Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
Marta Morado Arias, Jesús Villarrubia, Isidro Vitoria Miñana, et al.
Diseases (2025) Vol. 13, Iss. 4, pp. 102-102
Open Access
Lysosomal storage disorders
Derralynn Hughes
(2025), pp. 966-973
Closed Access
Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment
Raphael Schiffmann, James Turnbull, Robert Krupnick, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction
Costanza Ceni, Francesca Clemente, Francesca Mangiavacchi, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 453-453
Open Access | Times Cited: 3
Neuronopathic Gaucher disease: Rare in the West, common in the East
Özlem Göker-Alpan, Margarita M. Ivanova
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 5, pp. 917-934
Open Access | Times Cited: 3
Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson’s Disease
Laura López de Frutos, Francisco Almeida, Jessica Murillo‐Saich, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10387-10387
Open Access | Times Cited: 11
A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment
Wei Zhong, Dan Li, Yue Fei, et al.
Acta Neurologica Belgica (2024) Vol. 124, Iss. 4, pp. 1213-1223
Closed Access | Times Cited: 2
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report
Jianhui Zhang, Hui Chen, Dan‐dan Ruan, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1765-1774
Closed Access | Times Cited: 2
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease
Tama Dinur, Peter Bauer, Christian Beetz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3945-3945
Open Access | Times Cited: 6
Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma
Gianluca Bossù, Laura Pedretti, Lorenzo Bertolini, et al.
Children (2023) Vol. 10, Iss. 5, pp. 869-869
Open Access | Times Cited: 6
Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency
Eline C. B. Eskes, Martijn J. C. van der Lienden, Barbara Sjouke, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 4, pp. 107631-107631
Open Access | Times Cited: 5
Noninvasive DBS-Based Approaches to Assist Clinical Diagnosis and Treatment Monitoring of Gaucher Disease
Cláudia Rossi, Rossella Ferrante, Silvia Valentinuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2672-2672
Open Access | Times Cited: 5
Non-neuronopathic Gaucher disease (Type I) in an elderly female: a case report
Sujan Bohara, Sanjeet Bhattarai, Manoj Khadka, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 11, pp. 6780-6783
Open Access | Times Cited: 1
Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions
Siddhee A. Sahasrabudhe, Cheng Shen, Mahmoud Al‐Kofahi, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 6, pp. 1254-1263
Open Access | Times Cited: 7
Understanding patient and parent/caregiver perceptions on gene therapy in Gaucher disease: an international survey
Tanya Collin-Histed, Aviva Rosenberg, Noortje Hopman, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease
Esther Valero-Tena, Mercedes Roca-Espiau, José Verdú-Díaz, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Treatment-naive and post-treatment glucosylsphingosine (lyso-GL1) levels in a cohort of pediatric patients with Gaucher disease
Carly A. Rasmussen, Allegra Quadri, Erika Vucko, et al.
Molecular Genetics and Metabolism (2023) Vol. 141, Iss. 1, pp. 107736-107736
Closed Access | Times Cited: 2
Comprehensive and long‐term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3
Usanarat Anurathapan, Thipwimol Tim‐Aroon, Wujuan Zhang, et al.
Pediatric Blood & Cancer (2022) Vol. 70, Iss. 3
Open Access | Times Cited: 3
Gaucher Disease Coexisting with Cytomegalovirus Infection: A Rare Presentation in an Infant
Zhaoxia Zhang, Dong Liu, Zhangbin Yu, et al.
American Journal of Case Reports (2024) Vol. 25
Open Access
Gaucher’s Disease – current state of knowledge and future perspectives?
Katarzyna Szymańska, Julia Krasnoborska, Sylwia Samojedny, et al.
Journal of Education Health and Sport (2024) Vol. 64, pp. 131-148
Open Access
Importance of lysosomal storage diseases in rheumatology
Charlotte Aries, Cornelia Rudolph, Nicole Muschol
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 5, pp. 393-400
Closed Access
Page 1 - Next Page

Scroll to top